JEVA Sub-Q · 03 / 03
JEVA Sub-Q
Structural expression.
Hyaluronic acid with lidocaine · 1.1 ml
JEVA Sub-Q · 03 / 03
Beauty,
refined by
precision.
Hyaluronic Acid Filler · With lidocaine · 1.1 ml
At a glance.
A high-density dermal filler based on stabilised hyaluronic acid, developed for deep volumetric correction and facial sculpting at the level of the subcutaneous structures. As described in JEVA’s product catalogue.
Volume
1.1ml
Per product, as printed on the carton.
For professionals
Information intended for healthcare professionals.
Clinical details are provided in the official Instructions for Use and will be published here once supplied.
Presentation
A syringe sealed in a clear blister tray, carrying LOT and expiry labels for traceability.
Catalogue
Cross-linked Hyaluronic Acid Filler (Sub-Q)
A high-density dermal filler based on stabilised hyaluronic acid, developed for deep volumetric correction and facial sculpting at the level of the subcutaneous structures.
As described in JEVA’s product catalogue.
- 01Used for
- Pronounced volume restoration in the middle and lower thirds of the face
- Sculpting: cheekbones, chin, jawline
- Correction of age-related tissue loss
- Enhanced definition and facial architecture
- A lifting effect without surgery
- 02How it works
A maximum-density formula that:
- works in the deep layers, creating a strong supporting framework
- restores volume and shapes defined facial contours
- actively retains moisture, improving skin quality
- increases tissue density and firmness
- provides a lasting, structural result
- 03Advantages
- Maximum density — ideal for volumetric correction and contouring
- Pronounced lifting effect
- Long-lasting result
- Natural integration without migration
- Precise shaping of facial form and proportions
In detail.
Specifications
| Category | Hyaluronic acid filler |
|---|---|
| Variant | Sub-Q |
| Volume | 1.1 ml |
| Composition | Hyaluronic acid with lidocaine |
| Hyaluronic acid concentration | 24 mg/mL |
| Lidocaine concentration | 3 mg/mL (lidocaine HCl) |
| Cross-linking / gel technology | Cross-linked hyaluronic acid |
| Storage conditions | 2–25 °C |
| Country of manufacture | Made in Korea |
Needle specification · Shelf life · Manufacturer · Authorised representative · Registration / certification
Composition
| Cross-linked hyaluronic acid | 24 mg/mL |
|---|---|
| Lidocaine HCl | 3 mg/mL |
| Phosphate-buffered saline, pH 7 | q.s. |
| Other ingredients | None listed on the carton |
Packaging
| Outer carton | JEVA Sub-Q · 1.1 ml |
|---|---|
| Presentation | Syringe in a sealed blister tray |
| Traceability | Labels with LOT number and expiry date |
| Full contents per carton | 1 syringe and 1 sterilised needle |
| Symbols on carton | Single use · Sterile · Latex-free · Keep dry · Keep away from sunlight · Consult IFU |
Intended use.
- Pronounced volume restoration in the middle and lower thirds of the face
- Sculpting: cheekbones, chin, jawline
- Correction of age-related tissue loss
- Enhanced definition and facial architecture
- A lifting effect without surgery
As described in JEVA’s product catalogue. Clinical details, contraindications and administration are provided in the official Instructions for Use.
Injection depth and administration details will be published from the official Instructions for Use.
Documentation.
Official documents are published here as they are supplied. Professionals can request documentation directly.
Instructions for Use
Official IFU for JEVA Sub-Q.
- —
Warnings & precautions
As stated in the official IFU.
- —
Contraindications
As stated in the official IFU.
- —
Storage & handling
As stated in the official IFU.
- —
Manufacturer information
Legal manufacturer and address.
- —
Authorised representative
Where applicable.
- —
Certifications
Conformity and quality certificates.
- —
Product registration
Registration by market.
Enquire about JEVA Sub-Q.
For clinics, practitioners and distribution partners.
